2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole

C106H182N4O8 — CID 102441025

IUPAC2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole
SMILESCCCCCCCCCCCCCCOc1cc(-c2nnc(-c3ccc(-c4nnc(-c5cc(OCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCC)c5)o4)cc3)o2)cc(OCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCC
InChIInChI=1S/C106H182N4O8/c1-7-13-19-25-31-37-43-49-55-61-67-73-83-111-97-89-95(90-98(112-84-74-68-62-56-50-44-38-32-26-20-14-8-2)101(97)115-87-77-71-65-59-53-47-41-35-29-23-17-11-5)105-109-107-103(117-105)93-79-81-94(82-80-93)104-108-110-106(118-104)96-91-99(113-85-75-69-63-57-51-45-39-33-27-21-15-9-3)102(116-88-78-72-66-60-54-48-42-36-30-24-18-12-6)100(92-96)114-86-76-70-64-58-52-46-40-34-28-22-16-10-4/h79-82,89-92H,7-78,83-88H2,1-6H3
InChIKeyWARFFQNZEYIANE-UHFFFAOYSA-N
MW1640.64 g/mol
LogP35.60
Rot. Bonds88

About 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole

2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole (PubChem CID 102441025) has the molecular formula C106H182N4O8 and a molecular weight of 1640.64 g/mol. Its IUPAC name is 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole
PubChem CID102441025
Molecular FormulaC106H182N4O8
Molecular Weight1640.64 g/mol
Exact Mass1639.40
IUPAC Name2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole
SMILESCCCCCCCCCCCCCCOc1cc(-c2nnc(-c3ccc(-c4nnc(-c5cc(OCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCC)c5)o4)cc3)o2)cc(OCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCC
InChIInChI=1S/C106H182N4O8/c1-7-13-19-25-31-37-43-49-55-61-67-73-83-111-97-89-95(90-98(112-84-74-68-62-56-50-44-38-32-26-20-14-8-2)101(97)115-87-77-71-65-59-53-47-41-35-29-23-17-11-5)105-109-107-103(117-105)93-79-81-94(82-80-93)104-108-110-106(118-104)96-91-99(113-85-75-69-63-57-51-45-39-33-27-21-15-9-3)102(116-88-78-72-66-60-54-48-42-36-30-24-18-12-6)100(92-96)114-86-76-70-64-58-52-46-40-34-28-22-16-10-4/h79-82,89-92H,7-78,83-88H2,1-6H3
InChIKeyWARFFQNZEYIANE-UHFFFAOYSA-N
XLogP35.60
TPSA133.22 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds88
Heavy Atoms118
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001640.64
LogP ≤ 535.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
The IUPAC name of 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole (CID 102441025) is 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole is CCCCCCCCCCCCCCOc1cc(-c2nnc(-c3ccc(-c4nnc(-c5cc(OCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCC)c5)o4)cc3)o2)cc(OCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCC.
What is the InChIKey of 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
The InChIKey is WARFFQNZEYIANE-UHFFFAOYSA-N. The full InChI is InChI=1S/C106H182N4O8/c1-7-13-19-25-31-37-43-49-55-61-67-73-83-111-97-89-95(90-98(112-84-74-68-62-56-50-44-38-32-26-20-14-8-2)101(97)115-87-77-71-65-59-53-47-41-35-29-23-17-11-5)105-109-107-103(117-105)93-79-81-94(82-80-93)104-108-110-106(118-104)96-91-99(113-85-75-69-63-57-51-45-39-33-27-21-15-9-3)102(116-88-78-72-66-60-54-48-42-36-30-24-18-12-6)100(92-96)114-86-76-70-64-58-52-46-40-34-28-22-16-10-4/h79-82,89-92H,7-78,83-88H2,1-6H3.
What are the key properties of 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole has a molecular weight of 1640.64 g/mol, XLogP of 35.60, 88 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3,4,5-tri(tetradecoxy)phenyl]-5-[4-[5-[3,4,5-tri(tetradecoxy)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole is sourced from PubChem (CID 102441025), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).